News and Content
The Latest News from Agilex Biolabs
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Oligonucleotides, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have gai...
Author By Agilex BiolabsPosted on
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy! Agilex Biolabs is thrilled t...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO In the high-stakes world of drug development, biotech companies face unique challenges at every stage -...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Biomarkers are playing an increasingly important role in clinical studies where they can provide essenti...
Author By Agilex BiolabsPosted on
by Dr. Kurt Sales, Chief Scientific Officer Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been the preferred an...
Author By Agilex BiolabsPosted on
An exclusive delegation coming from Australia - where leading drug development experts will converge. The Agilex team would lik...
Author By Agilex BiolabsPosted on
Flow cytometry has become a powerful tool in the bioanalytical arsenal. In an era where pharmaceuticals are becoming more targe...
Author By Agilex BiolabsPosted on
Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolabs is celebrating its 29th year...
Author By Agilex BiolabsPosted on
For 3 decades, Agilex has supported biotech companies with CNS-targeted medicines. For almost 3 decades, Agilex Biolabs has sup...
Author By Agilex BiolabsPosted on
Let's face it – we are an aging population throughout the world. More and more, we are seeing these neurological disorders growi...
Author By Agilex BiolabsPosted on
In molecular biology and pharmacology, small molecules are noted for their ability to quickly modulate their actions. This is beca...
Author By Agilex BiolabsPosted on
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
Author By Agilex BiolabsPosted on
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin disorders like atopic dermatitis...
Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Jason so you could get to know him a bit better... My name is Jason Valentine. I'm...
Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
Author By Agilex BiolabsPosted on
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better... My name is Kurt Sales. I’m...
Author By Agilex BiolabsPosted on
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
Author By Agilex BiolabsPosted on
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Author By Agilex BiolabsPosted on
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Author By Agilex BiolabsPosted on
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The relationship between producin...
Author By Agilex BiolabsPosted on
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...
Author By Agilex BiolabsPosted on
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bioanalysis has undergone signif...